Drug Approval | August 16, 2023
Lupin's Mandideep Unit-2 facility completes USFDA inspection with no observations
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
The inspection was conducted from August 7 to August 11, 2023 and concluded without any observations.
Doxycycline Hyclate Delayed-Release Tablets USP (RLD Doryx ) had estimated annual sales of USD 9 million in the U.S. (IQVIA MAT June 2023).
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The medical device sector is considered as one of the sunrise sectors in the country
DKSH has further fortified its strategic partnership with Biolin Scientific, a globally recognized pioneer in surface science instrumentation, across nine key markets in the APAC region
Subscribe To Our Newsletter & Stay Updated
